This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.

Perrigo, a generic over-the-counter drug manufacturer, offers an attractive 8.3% dividend yield, but the article warns investors to be cautious. The company faces declining sales (down 3.1% YoY), weakening margins, and leadership uncertainty following the CEO's abrupt departure. While the dividend appears covered for now, risks include a shrinking business, potential asset sales, and the possibility of dividend cuts under new management.